Praxis Precision Medicines PRAX
NASDAQ PRAX
$252.96 -5.96 (-2.30%)
At close: Oct 23, 2026 · 4:00 PM EDT

Praxis Precision Medicines (PRAX) Cash & Current Investments (2019 - 2026)

Updated

Praxis Precision Medicines (PRAX) posted Cash & Current Investments of $758.55 million for Q2 2026, up 151.8% from $301.28 million a year earlier but down 3.6% from the prior quarter.

Analysis

Praxis Precision Medicines (PRAX) Cash & Current Investments (2019 - 2026) Analysis & Trends

At the end of FY2025, Praxis Precision Medicines' Cash & Current Investments came in at $599.33 million, up 52.7% from FY2024.

  • Annual Cash & Current Investments has increased for three consecutive years, with a five-year compound annual growth rate of 15.1% (FY2020 to FY2025).
  • In prior years, Praxis Precision Medicines' Cash & Current Investments was $392.57 million in FY2024 (+382.9%), $81.3 million in FY2023 (+31.9%), $61.62 million in FY2022 (-55.6%) and $138.7 million in FY2021 (-53.2%).
  • Quarterly Cash & Current Investments has run from a low of $56.04 million in Q2 2022 to a high of $786.87 million in Q1 2026 over five years.
  • On a year-over-year basis, Cash & Current Investments has increased in each of the last three quarters, with growth averaging 124.9% over the last eight quarters.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q4 2024, with growth of 382.9%; the weakest was Q2 2022, with a decline of 68.1%.
  • According to Business Quant data, Cash & Current Investments for the three prior quarters was $786.87 million (Q1 2026), $599.33 million (Q4 2025) and $267.16 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Praxis Precision Medicines 7.38 Bn 4.97 Bn - 758.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 758.55 Mn
Mar 31, 2026 786.87 Mn
Dec 31, 2025 599.33 Mn
Sep 30, 2025 267.16 Mn
Jun 30, 2025 301.28 Mn
Mar 31, 2025 327.99 Mn
Dec 31, 2024 392.57 Mn
Sep 30, 2024 357.03 Mn
Jun 30, 2024 351.88 Mn
Mar 31, 2024 207.42 Mn
Dec 31, 2023 81.30 Mn
Sep 30, 2023 101.09 Mn
Jun 30, 2023 124.30 Mn
Mar 31, 2023 80.84 Mn
Dec 31, 2022 61.62 Mn
Sep 30, 2022 62.44 Mn
Jun 30, 2022 56.04 Mn
Mar 31, 2022 77.85 Mn
Dec 31, 2021 138.70 Mn
Sep 30, 2021 165.68 Mn
API Access

Praxis Precision Medicines Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PRAX&period=max&api_key=YOUR_API_KEY